Elevated interleukin-6 and gamma-globulin during interferon therapy of hepatitis B.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1384310.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 49-yr-old man with chronic hepatitis B manifested hypergammaglobulinemia, lymphadenopathy, and a high serum interleukin-6 level following treatment with recombinant human alpha-interferon. One month later, when the patient was treated with natural beta-interferon, serum levels of interleukin-6 and gamma-globulin increased again. The serum gamma-globulin decreased to the pretreatment level after discontinuation of interferon therapy. The serum alanine aminotransferase level remained normal for 6 months. In this case, hypergammaglobulinemia and lymphadenopathy, as well as the elevated serum interleukin-6 level, were considered to be signs of highly enhanced humoral immunity related to alpha- and beta-interferon therapy.
Medical subject headings
- Hepatitis B
- Hepatitis, Chronic
- Hypergammaglobulinemia
- Interferon Type I
- Interferon-beta
- Interleukin-6
- Lymphatic Diseases